Skip to main content

Xolair and Covid-19 vaccine, what should I know?

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 23, 2024.

Official answer

by Drugs.com

If you are being treated with Xolair, you can be vaccinated with the COVID-19 vaccination at any time, but the ACAAI (American College of Allergy, Asthma, and Immunology) recommends that the COVID-19 vaccine and Xolair not be given on the same day since, if a reaction or a side effect occurs, it may be challenging to work out which injection was to blame. The ACAAI suggests separating the COVID-19 vaccination and Xolair by at least 24 hours. Other experts recommend separating these two injections by at least 48 hours. There is no reason to stop Xolair until you complete the course of the COVID-19 vaccinations.

Internationally, countries (such as Germany), recommend allowing a spacing of at least a week between the COVID-19 vaccination and a Xolair injection; however, this is not the position of the ACAAI.

Because Xolair works on the allergic arm of the immune system, it does not appear to compromise the immune system like traditional immunosuppressants, such as prednisone and cyclosporine. Xolair is not associated with an increased risk of infection nor increases the risk for COVID-19. If you are taking Xolair for asthma, nasal polyps, urticaria, or to prevent allergic reactions in Ig-E-mediated food allergies, you are not at increased risk for allergic reactions after the COVID-19 vaccination. There is no data to suggest that biologics have any effect (good or bad) on a person’s response to a COVID-19 vaccine including a booster injection. Only patients on daily oral corticosteroids of 20mg or more are considered immunocompromised by the CDC.

References
  • Pfaar, O., Klimek, L., Hamelmann, E., Kleine-Tebbe, J., Taube, C., Wagenmann, M., Werfel, T., Brehler, R., Novak, N., Mülleneisen, N., Becker, S., & Worm, M. (2021). COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA). Allergologie select, 5, 140–147. https://doi.org/10.5414/ALX02241E
  • Frequently Asked Patient Questions About the COVID-19 Vaccine. American College of Allergy, Asthma, and Immunology. https://acaai.org/news/allergy/
  • Xolair Product Information. https://www.gene.com/download/pdf/xolair_prescribing.pdf

Read next

What are monoclonal antibodies?

Monoclonal antibodies (mAbs) are man-made proteins that mimic the natural antibodies produced by our immune systems. Monoclonal antibodies can be formulated into medicines to treat various types of illnesses, such as cancer, rheumatoid arthritis or psoriasis. Continue reading

Is Xolair an immunosuppressant?

Xolair does act on the body’s immune system to prevent an allergic response, but because it only acts on the allergic arm of the immune system, it does not appear to compromise the immune system as other immunosuppressants do. Xolair is not like traditional immunosuppressants, such as prednisone or cyclosporine because it does not increase the risk of infection nor the risk of COVID-19. Continue reading

How long before Xolair starts working?

Free serum IgE levels are decreased within an hour of Xolair administration. However it may take several months for the full effects of Xolair to be seen, although some symptom improvement may be noted after a few weeks. Significant improvements were noted after 4 months in those with allergic asthma, after 3 months in those with chronic urticaria, and after 16 to 20 weeks in those with Ig-E-mediated food allergies. Continue reading

Related medical questions

Drug information

Related support groups